Commentary on: the management of patients with gastric intestinal metaplasia
Abstract
No abstract availableKeywords
Funding Information
- Cancer Prevention and Research Institute of Texas (RP220127)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK56338)
This publication has 10 references indexed in Scilit:
- The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelinesGut, 2024
- Cost‐Effectiveness of Population‐Based Helicobacter pylori Screening With Eradication for Optimal Age of ImplementationHelicobacter, 2024
- Simplified Helicobacter pylori therapy for patients with penicillin allergy: a randomised controlled trial of vonoprazan-tetracycline dual therapyGut, 2024
- RE.GA.IN.: the Real-world Gastritis Initiative–updating the updatesGut, 2024
- Vonoprazan‐amoxicillin dual therapy versus bismuth‐containing quadruple therapy for Helicobacter pylori eradication: A systematic review and meta‐analysisHelicobacter, 2023
- Autoimmune gastritis: long-term natural history in naïve Helicobacter pylori -negative patientsGut, 2022
- Global Antimicrobial Stewardship with a Focus on Low- and Middle-Income Countries: A position statement for the international society for infectious diseasesInternational Journal of Infectious Diseases, 2020
- Guilt by associationCurrent Opinion in Gastroenterology, 2018
- What is antimicrobial stewardship?Clinical Microbiology and Infection, 2017
- Atrophic gastritis in young children and adolescentsJournal of Clinical Pathology, 2005